Home 2021
Yearly Archives: 2021
Alzheimer’s disease: Hormone irisin has the ability to drive the cognitive benefits of exercise
The novel hormone irisin has the ability to drive the cognitive benefits of exercise, and therefore holds great promise for treating cognitive decline in...
Gut microbiome plays a key role in metabolizing flavonoids to enhance their cardioprotective effects
Flavonoid-rich foods, including berries, apples, pears and wine, appear to have a positive effect on blood pressure levels, an association that is partially explained...
COVID-19: efficacia di una dose extra/di richiamo del vaccino mRNA
L'infezione da SARS-COV-2 può essere asintomatica ma può anche portare a gravi malattie da Covid-19 e morte. La trasmissione del virus per via aerea è...
COVID-19 mRNA vaccine effectiveness lower to 53% during Delta strain era
mRNA COVID-19 vaccines provide protection against infection among nursing home residents, but the vaccine effectiveness was lower after the delta variant became the predominant...
Hearing loss may act as a cause of depression in older people
University of Manchester researchers have discovered that hearing loss may act as a cause of depression in older people.
And those in the lowest wealth...
Alzheimer: regular physical exercise modulates iron metabolism in both the brain and the muscles
A recent experimental study shows how regular physical exercise modulates iron metabolism in both the brain and the muscles. The findings also help to...
COVID-19: effectiveness of an extra/booster dose of mRNA vaccine
Background
Infection with SARS-COV-2 can be asymptomatic but also lead to very severe Covid-19 illness and death. Airborne transmission of the virus is the common...
Il farmaco per il bruciore di stomaco Famotidina migliora le probabilità di sopravvivenza per...
Nei primi giorni della pandemia di COVID-19, i medici di Wuhan hanno notato qualcosa di sorprendente.
Molti dei pazienti anziani sopravvissuti al virus erano poveri:...
Il trattamento con gli anticorpi AstraZeneca ha mostrato un rischio ridotto del 77% di...
Venerdì l'azienda farmaceutica AstraZeneca ha annunciato risultati positivi da una sperimentazione di un trattamento per i sintomi di COVID-19.
Il farmaco, costituito da una combinazione...
Treatment with AstraZeneca antibodies showed a 77% reduced risk of developing symptomatic disease
Drug firm AstraZeneca on Friday announced positive results from a trial of a treatment for COVID-19 symptoms.
The drug, made from a combination of two...
Heartburn drug Famotidine improve the odds of survival for COVID-19 patients
In the early days of the COVID-19 pandemic, doctors in Wuhan noticed something surprising.
Many of the elderly patients who survived the virus were...
COVID-19: l’anticorpo SARS2-38 ha neutralizzato facilmente tutte le varianti
Il virus che causa il COVID-19 oggi non è lo stesso che ha ammalato per la prima volta le persone nel dicembre 2019. Molte...
COVID-19: SARS2-38 antibody easily neutralized all the variants
The virus that causes COVID-19 today is not the same as the one that first sickened people way back in December 2019. Many of...
Plant-based vaccine for COVID-19
A pair of researchers at Université Laval, Quebec claim that more effort should be made to develop plant-based vaccines. Hugues Fausther-Bovendo and Gary Kobinger...
Neurograins BCI independently record electrical impulses and send signals wirelessly
Brain-computer interfaces (BCIs) are emerging assistive devices that may one day help people with brain or spinal injuries to move or communicate.
BCI systems...
